Abstract

Euro cancer conference is a premier event which is designed for global platforms to show the latest advancements in cancer research. The Conference make available for the use of platform for researchers, scientists, people pretend by cancer and industries to come together to review, present and showcase high-quality research. Informative and interactive educational conference attracts delegates each year and creates the ideal setting to establish new collaborations with key collaborators in cancer research. The theme of the conference is “Global challenges in targeting of cancer and its therapeutic advances” which reflects the various elements of cancer research along the transitional research continuum. Cancer has a major impact across the worldwide; Cancer is among the leading disease and causes of death worldwide. In 2012, there were approximately 14.1 million new cases and 8.2 million cancer-related deaths worldwide were estimated. Around 50% of new cancer cases in 2012 occurred in less developed regions of the world that include Central America and parts of Africa and Asia; 65% of cancer deaths also occurred in these regions. Based on the function, the cancer diagnostics market is divided into Lung cancer, Breast cancer, Melanoma, and others. Breast cancer application was expected to recognize for a major share of the cancer diagnostics market, by application in 2016. In 2017, about 91.5 million people had cancer. Nearly 15 million new cases occur a year. It caused about 8.8 million deaths (17.7% of deaths). In females, the common types of cancers are breast cancer, colorectal cancer, lung cancer and cervical cancer. If skin cancer and other melanoma were included in new cancer cases each year, it would account for around 40-45% of cases. Based on field, the market is divided into North America, Europe, Asia, and the entire World. The World part includes Latin America, Pacific countries, and Middle East and Africa. Approximately 10 million deaths in 2017. The number of new cancer cases per year is expected to rise to 23 million by 2030. Some of the past conference speakers: Ping Yang, Mayo Clinic College of Medicine, USA Carmen pingarron santofimia, Hospital San Jose Quironsalud, Spain Rebeka Mortha, Tata Memorial Hospital, India Nicola Radovik, University of Hospital Center Zagreb, Croatia Besarion Partsvania, Georgian Technical University, Georgia Adel K. Al- Naggar, The University of Texas MD Anderson Cancer center, USA Muralee Damodaran, HSR Divisions, AIMS, India Xiaoyang yang, Yale University, USA Hiroshi Kobayashi, Chiba University, Japan Fidelia S. Lau, The Hong Kong polytechnic University, Hong Kong Minh Doan Nguyen, Mayo clinic, USA Petra Priscakova, Univerzita Komenskeho, Slovakia Helena Gbelkova, Comenius University, Slovakia